Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64,565,461
+$5,074,724 QoQ
Shares Held
129,981
-2.4% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#153
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,717 across 210 Biotechnology names. VRTX ranks #3 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,565,461 | 129,981 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $59,490,737 | 133,226 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $165,033,466 | 364,023 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $69,135,032 | 176,527 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $132,403,814 | 297,403 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $142,431,388 | 293,782 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $110,796,863 | 275,135 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $99,481,076 | 213,901 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $99,770,332 | 212,857 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $89,650,186 | 214,469 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $146,217,548 | 359,354 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $138,824,065 | 399,218 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $140,384,287 | 398,921 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $81,429,840 | 258,450 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $21,465,882 | 74,333 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $32,303,397 | 111,568 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,921,223 | 88,439 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,506,166 | 44,090 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,538,647 | 34,329 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,461,110 | 35,620 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,753,966 | 43,416 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $9,917,602 | 46,152 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $17,983,346 | 76,091 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $32,632,902 | 119,921 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $35,623,939 | 122,710 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $32,399,270 | 136,160 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||